Page last updated: 2024-09-05

sb 203580 and Pulmonary Arterial Remodeling

sb 203580 has been researched along with Pulmonary Arterial Remodeling in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bryson, G; Church, AC; Fisher, AJ; Martin, DH; Peacock, AJ; Wadsworth, R; Welsh, DJ	1

Other Studies

1 other study(ies) available for sb 203580 and Pulmonary Arterial Remodeling

Article	Year
The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension. American journal of physiology. Lung cellular and molecular physiology, 2015, Aug-15, Volume: 309, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Cell Hypoxia; Cell Proliferation; Female; Fibroblasts; Humans; Hypertension, Pulmonary; Imidazoles; Interleukin-6; Male; Mitogen-Activated Protein Kinase 14; Pulmonary Artery; Pyridines; Rats, Sprague-Dawley; Vascular Remodeling	2015

Article

Year

The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension.

American journal of physiology. Lung cellular and molecular physiology, 2015, Aug-15, Volume: 309, Issue:4

Topics: Animals; Anti-Inflammatory Agents; Cell Hypoxia; Cell Proliferation; Female; Fibroblasts; Humans; Hypertension, Pulmonary; Imidazoles; Interleukin-6; Male; Mitogen-Activated Protein Kinase 14; Pulmonary Artery; Pyridines; Rats, Sprague-Dawley; Vascular Remodeling

2015